Nathan Devery News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nathan Devery. Real-time updates on events, politics, business and more.

B cells drive responses of other immune cells, can be modified to prevent multiple sclerosis symptoms

May 21, 2024

Penn Medicine research finds that abnormally active B cell metabolism causes an inflammatory immune response in individuals with MS.

Nathan Devery Or Of Perelman School Medicine Penn Center Amit Bar Or Perelman School Science Immunology

Source: upenn.edu

FDA Grants Priority Review to Repotrectinib for the Treatment of NTRK-Positive Solid Tumors

February 14, 2024

Repotrectinib led to a durable anti-tumor response in patients with NTRK-positive locally advanced or metastatic solid tumors.

Joseph Fiore Nathan Devery Bristol Myers Squibb

Source: pharmacytimes.com

Larotrectinib Subgroup Analyses Demonstrate Long-Term Efficacy, Safety Profile in NTRK Gene Fusion Cancer

June 2, 2023

Findings presented at the American Society of Clinical Oncology (ASCO) 2023 meeting show the long-term efficacy and safety profile of larotrectinib (Vitrakvi; Bayer) in solid tumors with NTRK gene fusion.

United States Iain Webb Nathan Devery Us Medical Affairs American Society Of Clinical Oncology American Society

Source: pharmacytimes.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Nathan Devery News Today

B cells drive responses of other immune cells, can be modified to prevent multiple sclerosis symptoms

FDA Grants Priority Review to Repotrectinib for the Treatment of NTRK-Positive Solid Tumors

Larotrectinib Subgroup Analyses Demonstrate Long-Term Efficacy, Safety Profile in NTRK Gene Fusion Cancer

Explore More Categories